Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Newmont Mining Corp (NEM): Drop in Gold Prices May be Final Straw for This Struggling Miner

Page 1 of 2

As the crisis in Syria appears headed toward a resolution, key commodities markets are no longer on edge. Oil prices have begun to slip, and gold prices have resumed their downward trajectory, making a quick retreat from their 150-day moving average.

Falling gold prices can spell serious trouble for gold miners. In recent years, mining costs have steadily increased due to higher labor costs, a greater regulatory burden and a move toward more deeply buried seams of gold. As an example, Barrick Gold Corporation (USA) (NYSE:ABX) has taken a $5.1 billion charge to reflect higher costs at its new Pascua-Lama mine.

Gold prices have been under pressure since this spring when analysts at Goldman Sachs Group, Inc. (NYSE:GS) suggested that there was no fundamental reason for gold prices to remain above $1,500, especially since inflationary fears have increasingly proved to be unfounded.

At the time, they predicted that gold would fall to $1,200 or $1,300 an ounce in the near term, and perhaps lower in the long term.

In a Sept. 16 note to clients, Goldman’s Jeffrey Currie provided an updated view: “We continue to expect that gold prices will resume their decline heading into 2014 when we expect economic data to solidly confirm a reacceleration in US growth and warrant a less accommodative monetary policy stance. Our end of 2014 price forecast therefore is unchanged at $1,050/oz, implying 20% downside potential from current prices.”

Currie also suggested another negative catalyst may knock gold prices down even more. “The recent pressure on [emerging market] economies and current accounts could accelerate the decline in gold prices as it forces such countries to slow their domestic gold demand, imports and reserve accumulation.”

The difference between $1,300 gold and $1,000 gold means the difference between profits and losses at many mines. This is painful enough for any gold miner that must buckle down and wait for the next cyclical upturn for gold. But Newmont Mining Corp (NYSE:NEM) doesn’t have the luxury of time.

In 2012, this gold miner spent $3.2 billion on mine development, which was roughly twice the company’s 10-year average. To pay for that, total debt swelled from $4.3 billion at the end of 2011 to $6.3 billion at the end of 2012.

Currently, NEM’s total debt is listed at $6.77 billion, and the company said it plans to spend more than $2 billion this year to complete mining development work that began a year or two ago. Analysts at Citigroup Inc. (NYSE:C) think the company will need to deploy a further $3.5 billion in capital spending spread over the next two years as well.

Meanwhile, the recent plunge in gold and copper prices led Newmont Mining Corp (NYSE:NEM) to write off more than $2 billion from its stated asset value when quarterly results were released in late July. If commodity prices fall further and stay down for several years, Newmont’s debt load may start to force the company to sell assets, likely at prices well below what it spent to acquire them. That’s the peril of a spending spree at the peak of a market.

At this juncture, you would expect Wall Street analysts to begin stress-testing the gold miners to see how they would fare in an environment of collapsing gold prices. Instead, a quick sampling of Wall Street research implies a head-in-the-sand approach.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!